MacroGenics
MGNX
#8794
Rank
A$0.34 B
Marketcap
A$5.35
Share price
5.35%
Change (1 day)
98.01%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of June 2026 : A$0.24 Billion

According to MacroGenics's latest financial reports the company has A$0.24 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$0.28 B-12.55%
2024-12-31A$0.32 B-3.88%
2023-12-31A$0.33 B48.72%
2022-12-31A$0.22 B-32.5%
2021-12-31A$0.33 B-5.19%
2020-12-31A$0.35 B15.01%
2019-12-31A$0.30 B-6.77%
2018-12-31A$0.33 B-15.42%
2017-12-31A$0.39 B1.71%
2016-12-31A$0.38 B-17.43%
2015-12-31A$0.46 B141.7%
2014-12-31A$0.19 B47.46%
2013-12-31A$0.13 B184.24%
2012-12-31A$45.94 M-14.69%
2011-12-31A$53.85 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
A$16.74 B 6,649.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$12.80 B 5,064.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.01 B 7,971.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$4.54 B 1,734.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.21 B 4,020.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$15.83 B 6,285.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.65 B 163.38%๐Ÿ‡บ๐Ÿ‡ธ USA